Clinical Trial Update: Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating apatinib plus chemotherapy versus chemotherapy in second-line gastric cancer after prior anti-PD-1 therapy; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric Cancer, Randomized Controlled Study | Phase 4 | Status: UNKNOWN